Lantern Pharma Inc.LTRNNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
2.50%
↑ 120% above average
Average (26q)
-12.47%
Historical baseline
Range
High:48.94%
Low:-92.86%
Volatility
-1136.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 2.50% |
| Q2 2025 | 4.76% |
| Q1 2025 | 22.22% |
| Q4 2024 | -28.57% |
| Q3 2024 | 8.70% |
| Q2 2024 | 9.80% |
| Q1 2024 | -30.77% |
| Q4 2023 | -34.48% |
| Q3 2023 | 34.09% |
| Q2 2023 | -37.50% |
| Q1 2023 | -3.23% |
| Q4 2022 | -40.91% |
| Q3 2022 | 47.62% |
| Q2 2022 | -10.53% |
| Q1 2022 | -18.75% |
| Q4 2021 | 11.11% |
| Q3 2021 | -71.43% |
| Q2 2021 | 12.50% |
| Q1 2021 | 48.94% |
| Q4 2020 | -74.07% |
| Q3 2020 | -92.86% |
| Q2 2020 | -76.99% |
| Q1 2020 | 28.09% |
| Q4 2019 | 0.00% |
| Q3 2019 | -10.00% |
| Q2 2019 | -36.99% |
| Q1 2019 | 0.00% |